Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Live attenuated classical swine fever vaccine based in genetic manipulation of a putative fusion peptide area in the virus structural glycoprotein E2

Live attenuated classical swine fever vaccine based in genetic manipulation of a putative fusion peptide area in the virus structural glycoprotein E2

US Patent 9814771 · Granted Nov 14, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Development of a novel live attenuated African Swine Fever vaccine based in the 2023
Development of a novel live attenuated African Swine Fever vaccine based in the 2023
Development of a novel live attenuated African swine fever vaccine based in the 2023
Development of a novel live attenuated African swine fever vaccine based in the 2023
Continuous stable cell line for identification of infectious African swine fever2023
Continuous stable cell line for identification of infectious African swine fever2023
Genomic deletion in African swine fever vaccine allowing efficient growth in sta2023
Genomic deletion in African swine fever vaccine allowing efficient growth in sta2023
Development of a novel live attenuated African Swine Fever vaccine based in the 2021
Development of a novel live attenuated African Swine Fever vaccine based in the 2021
Rationally developed african swine fever attenuated virus strain protects agains2017
Rationally developed african swine fever attenuated virus strain protects agains2017